PTGS2 and early-onset autosomal dominant Alzheimer disease: Also cyclooxygenase-2 (COX-2) inhibitors are an interesting target of research, due to the fact that the progression of Alzheimer’s disease was slowed down by using anti-inflammatory drugs.